Employers are facing a changing landscape when it comes to healthcare, whether it’s in regards to mental health concerns for their employees, cancer driving up health costs or the increase in prescription drug prices. To understand employers’ key concerns and their strategies to address these concerns, the Business Group on Health surveyed 152 large, self-insured … Read more
About 100,000 nurses left their jobs in the past two years, and another 610,388 are likely to leave the profession by 2027. This nursing shortage leaves those who are still working in the profession with insufficient capacity to handle patient needs, leading to high levels of burnout and emotional strain that end up driving even … Read more
Artificial intelligence certainly isn’t new to the digital health field, but the sector seems to be in the midst of a new hype cycle. This one is focused on novel technologies like large language models and other forms of generative AI, said Alex Lennox-Miller, lead analyst at CB Insights, during a Thursday webinar. The healthcare … Read more
Just about every woman goes through menopause in their life. Yet, less than one in five OB/GYNs receive formal training in menopause care, creating a massive gap in support. Progyny hopes to fill this gap by launching a menopause offering for employers. The New York City-based benefits management company has traditionally specialized in fertility and … Read more
Of the roughly 780,000 Americans who live with end-stage kidney disease, 71% are on some form of dialysis. Dialysis can provide an effective life-sustaining treatment for many with kidney failure, but it is not the best option for most. First, there’s the commute to a nephrology clinic or dialysis center, which for patients in rural … Read more
A split Food and Drug Administration decision on a new depression medicine from Sage Therapeutics and Biogen blew holes in the strategies of both companies and raised questions about the future of their collaboration. Late on Friday, the FDA approved a two-week course of the pill Zurzuvae as a treatment for postpartum depression, but not … Read more
The market is buzzing with demand for obesity pills, but Allurion Technologies is building a case that its weight loss platform—a medical device and software—is a worthy competitor to these drugs and perhaps even a companion to them. The company made debuted on the stock market debut Wednesday, raising $100 million to support commercialization of … Read more
Hospitals, and especially nonprofit hospitals, have a duty of care to their communities, but their ability to provide that care hinges on their ability to generate revenue – chiefly in the form of patient and insurer payments. But that model is growing more difficult as the commercially insured population ages into Medicare and those with employer-sponsored … Read more
The $76 Billion Diet Industry Asks: What to Do About Ozempic? The Wall Street Journal Source link